-
Factors affecting adaptive deep brain stimulation (aDBS) indications in Parkinson’s disease
-
Factors influencing health-related quality of life of patients with spinocerebellar ataxia
-
Factors influencing voice function after deep brain stimulation in Parkinson’s disease
-
Failure of model-based outcome monitoring in Parkinson’s Disease Apathy
-
Falls in Mild Cognitive Impairment with Lewy bodies (MCI-LB).
-
Familial Parkinson’s: Epidemiological data at Blida University Hospital.
-
Feasibility and acceptability of implementing dignity therapy as a supportive intervention for people with movement disorders.
-
Feasibility and efficacy of a multidisciplinary telemedicine intervention program to reduce falls and gait impairment in Parkinson’s disease (NCT04694443).
-
Feasibility, Reliability and Value of Remote Levodopa Challenge Test in Parkinson’s Disease
-
Fecal tyrosine decarboxylase and motor response complications in Parkinson’s Disease
-
Feeding dystonia revealing Huntington’s disease, about a case
-
FGF14 repeat expansions: Case series of adult-onset cerebellar ataxia patients from Serbia
-
Filipino’s and Parkinson’s Disease: A Scoping Review of the Literature
-
Financial impact of Parkinson’s disease on women and men
-
First approach of a sensor-based assessment of the camptocormia angle
-
First case of sporadic ATP6AP2 Mutation reported in Asia in a Parkinson’s Disease patient
-
First Case Series on the use of a High Frequency Vibrotactile Stimulation and Cueing Device in Panama
-
First Report of ERCC1-Associated Adult-Onset Hepatocellular Carcinoma, Ataxia, and Cognitive Decline
-
Flavonoid intake and risk of Parkinson’s Disease
-
Fluorescence-lifetime ophthalmoscopy findings in Parkinson’s disease patients with visual disturbances
-
Focused ultrasound as rescue treatment of essential tremor after deep brain stimulation.
-
Foslevodopa/foscarbidopa in patients with advanced Parkinson’s disease: subgroup analyses from a phase 3, randomized study
-
Foslevodopa/foscarbidopa subcutaneous infusion shows similar infusion site reaction severity score across range of infusion rates in patients with Parkinson’s disease
-
Fragile X Related Tremor in FMR1 Premutation Women without FXTAS
-
Free water imaging of the cholinergic forebrain in body vs. brain-first Parkinson’s disease subtypes
-
Free water neuro-imaging changes as the biomarker in new diagnosis of Wilson’s disease
-
Free-viewing eye tracking in Parkinson’s disease and correlation with clinical features
-
Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life
-
Frequency coding mechanism of tremor in the cerebellar circuitry
-
Frequency of Parkinson disease following COVID-19 infection: a two-year retrospective cohort study
-
Frequency of Parkinson’s Disease in All Case Hospitalization Among Native Hawaiian/Pacific Islanders, Asian American Subgroups and Whites
-
Frequency of SCA 2, 3 and 7 in Slovak patients with spinocerebellar ataxia – first report of SCA2 patient from Slovakia
-
FRMD5 de novo variants in two cases with childhood onset ataxia and seizures
-
From foot to head: look after your socks !
-
From the Healthy Brain Ageing – HeBA – Cohort: Motivation for participating in the first online phase of HeBA
-
From the Healthy Brain Ageing (HeBA) Cohort: Frequency of key risk factors for Parkinson in a European Cohort
-
Functional brain network alterations in the prodromal phase of X-linked dystonia-parkinsonism
-
Functional circuit abnormalities in Levodopa-induced dyskinesia in Parkinson’s disease: A systematic review
-
Functional connectivity fingerprints in Parkinson’s disease patients with hallucinations
-
Functional movement disorders in dopa-responsive dystonia – A case series with implications for diagnosis and treatment
-
Functional network correlates of APOE ε4 allele in Parkinson’s disease
-
Functional Neuroimaging and Follow up trends in Drug induced movement disorders.
2023 International Congress
August 27-31, 2023. Copenhagen, Denmark.